CTD regulations will be obligatory to new drug application, KFDA says

The Korea Food and Drug Administration says the common technical document (CTD) related regulations will be compulsorily applicable to new drug application from this March, but its full implementation to other medicines will be flexible depending on the industry’s general environments.

An applicant should only prepare the following data in the form of CTD among the safety and efficacy data o...